108 related articles for article (PubMed ID: 21461582)
1. Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk.
Ziva Cerne J; Stegel V; Gersak K; Novakovic S
Mol Med Rep; 2011; 4(1):175-9. PubMed ID: 21461582
[TBL] [Abstract][Full Text] [Related]
2. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.
Le Marchand L; Haiman CA; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2071-7. PubMed ID: 15598763
[TBL] [Abstract][Full Text] [Related]
3. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
4. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
6. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study.
Karagas MR; Park S; Nelson HH; Andrew AS; Mott L; Schned A; Kelsey KT
Int J Hyg Environ Health; 2005; 208(5):321-7. PubMed ID: 16217917
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
10. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the contribution of methylenetetrahydrofolate reductase genotypes to Taiwan breast cancer.
Huang CY; Chang WS; Shui HA; Hsieh YH; Loh CH; Wang HC; Ji HX; Hsiao CL; Hsu CM; Tsai CW; Bau DT
Anticancer Res; 2014 Aug; 34(8):4109-15. PubMed ID: 25075036
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Langsenlehner T; Renner W; Yazdani-Biuki B; Langsenlehner U
Breast Cancer Res Treat; 2008 Feb; 107(3):459-60. PubMed ID: 17453338
[TBL] [Abstract][Full Text] [Related]
14. The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk.
Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Wolf G; Wascher TC; Paulweber B; Weitzer W; Samonigg H
Breast Cancer Res Treat; 2003 Sep; 81(2):169-72. PubMed ID: 14572159
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
16. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.
Chen J; Gammon MD; Chan W; Palomeque C; Wetmur JG; Kabat GC; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Santella RM
Cancer Res; 2005 Feb; 65(4):1606-14. PubMed ID: 15735051
[TBL] [Abstract][Full Text] [Related]
17. [MTHFR polymorphisms, dietary folate intake and risks to breast cancer].
Gao CM; Kazuo T; Tang JH; Cao HX; Ding JH; Wu JZ; Wang J; Liu YT; Li SP; Su P; Keitaro M; Toshiro T
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):576-80. PubMed ID: 19954067
[TBL] [Abstract][Full Text] [Related]
18. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
20. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
